Skip to main content
. 2019 Apr 24;13:715–721. doi: 10.2147/OPTH.S196105

Table 3.

Incidence of all adverse events for phaco-KDB patients with severe glaucoma (n=42)

Adverse event 1 day 1 week 1 month 3 months 6 months
Microhyphemaa 30 (71.4%) 2 (4.9%)
Hyphemab
ERM 1 (2.4%)
CME 2 (5.3%)

Notes:

a

Microhyphema: suspended red blood cells in the anterior chamber.

b

Hyphema: layered blood occupying the anterior chamber.

Abbreviations: CME, cystoid macular edema; ERM, epiretinal membrane; phaco-KDB, Kahook Dual Blade combined with phacoemulsification.